Delivery Order SPE2DB22D1202-SPE2DB25FUUP2
Award Date
3/6/25
Potential Completion Date
3/7/25
Potential Value
$5.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OTREXUP 22.5 MG/0.4 ML AUTOINJ 0.4ML. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,427.22 and an ultimate completion date of August 21, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,622.71, is for the delivery of OTREXUP 20 MG/0.4 ML AUTO-INJ 0.4ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
This contract award is for Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide OTREXUP 22.5 MG/0.4 ML AUTOINJ 0.4ML medical products to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,530.24 and runs through February 2025. It is a delivery order contract with a firm fixed price pricing type. The award is not associated with any set-aside requirements. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for OTREXUP 15 MG/0.4 ML AUTO-INJ 0.4ML, a specialty pharmaceutical product, with a ceiling value of $2,599.92 and a period of performance through March 25, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,428.99 firm fixed price delivery order is for the supply of OTREXUP 15 MG/0.4 ML AUTO-INJ 0.4ML, a specialty pharmaceutical product. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award, valued at $1,841.68, was issued by the Defense Logistics Agency (DLA) to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of OTREXUP 15 MG/0.4 ML AUTO-INJ 0.4ML, a medication, with a completion date of July 12, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
This contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the provision of OTREXUP 20 MG/0.4 ML AUTO-INJ 0.4ML, a medical product. The delivery order is valued at $1,544.06 and has a period of performance through January 18, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as...
This federal contract award, with ID SPE2DB22D6029|SPE2DB24FU1WT, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,603.31 firm-fixed-price delivery order is for the supply of OTREXUP 20 MG/0.4 ML AUTO-INJ 0.4ML, a pharmaceutical product. The contract has an ultimate completion date of August 5, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with numerous...
Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order valued at $2,725 by the Defense Logistics Agency Troop Support Medical to supply OTREXUP 25 MG/0.4 ML AUTO-INJ 0.4ML pharmaceutical products. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all supplies delivered by December 19, 2023. No set aside designation was applied to this order, which was issued against an existing indefinite delivery contract held by Amerisourcebergen...
This award is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract, valued at up to $999,999,999 through December 2025. The contract was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to supply a range of medical commodities including pharmaceutical products, vaccines, and medical supplies to support military treatment programs and federal healthcare facilities nationwide. The specific items awarded in...